PTH-088 Prevalence of low drug levels and anti-drug antibodies in an unscreened population of patients with inflammatory bowel disease receiving infliximab
Sign Up to like & getrecommendations! Published in 2017 at "Gut"
DOI: 10.1136/gutjnl-2017-314472.487
Abstract: Introduction Infliximab (IFX) is widely used for induction and maintenance of remission in inflammatory bowel disease (IBD). It has been suggested that monitoring drug levels and antibodies to infliximab (ATI) may allow treatment optimisation. The… read more here.
Keywords: bowel disease; pth 088; drug levels; inflammatory bowel ... See more keywords